Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1996 | 09-1996 | 06-1996 | 03-1996 | 12-1995 | |
| Sales | 3,717 | 2,175 | 5,354 | 5,153 | 2,929 |
| Cost of Goods | 2,226 | 2,252 | 2,989 | 3,305 | 2,772 |
| Gross Profit | 1,492 | 2,188 | 2,365 | 1,848 | 397 |
| Operating Expenses | 3,295 | 4,327 | 5,193 | 3,902 | 4,801 |
| Operating Income | -1,578 | -4,152 | -1,839 | -1,749 | -3,872 |
| Interest Expense | 290 | 320 | 314 | 299 | 242 |
| Other Income | -1,343 | 2,382 | 95 | 29 | -415 |
| Pre-tax Income | -3,211 | -2,090 | -2,058 | -2,019 | -4,529 |
| Income Tax | 0 | 0 | 0 | 0 | -21 |
| Net Income Continuous | -3,211 | -2,090 | -2,058 | -2,019 | -4,747 |
| Net Income | $-3,211 | $-2,090 | $-2,058 | $-2,019 | $-4,747 |
| EPS Basic Total Ops | -14.40 | -8.80 | -8.80 | -9.60 | -22.40 |
| EPS Basic Continuous Ops | -14.04 | -9.17 | -9.11 | -9.31 | -22.70 |
| EPS Diluted Total Ops | -14.40 | -8.80 | -8.80 | -9.60 | -22.40 |
| EPS Diluted Continuous Ops | -14.04 | -9.17 | -9.11 | -9.31 | -22.70 |
| EBITDA(a) | $-1,443 | $-3,733 | $-1,417 | $-1,331 | $-3,872 |